Anthem Biosciences Limited is an India-based contract research, development and manufacturing organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. The Company helps new and established biotech’s and big pharma, develop, optimize and test proteins, monoclonal antibodies, peptides, large molecules, small molecules, toxins and much more. In addition to product research and development, it helps test drugs for safety, efficacy (in vitro and in vivo), pre-clinical animal studies in a GLP facility, clone development, antibody drug conjugates, research and development and manufacture of highly potent compounds, flow chemistry-based production and large-scale commercial product manufacture. Its product line includes human nutrition, animal health, and industrial products. Under human nutrition, it offers active pharmaceutical ingredients, dietary supplements, probiotics, and enzymes, among others.As of 25 May 2026, ANTHEM BIOSCIENCES LTD share price is ₹765.35. The stock opened at ₹777.10, compared to its previous close of ₹777.10. During today's trading session, ANTHEM BIOSCIENCES LTD share price moved in the range of ₹761.25 to ₹786.40, with an average price of ₹773.83 for the day. Looking at its last 52-week, the stock has touched a low of ₹761.25 and a high of ₹786.40. On the performance front, ANTHEM BIOSCIENCES LTD share price has increased by 22.36% over the last six months and is up 6.40% on a year-on-year basis.
The market capitalization of ANTHEM BIOSCIENCES LTD is ₹43,735 Crs, with a P/E ratio of 73.9 and a dividend yield of 0.00%.